
Cat. #157729
pCRBLUNT-HBsAg Vector
Cat. #: 157729
Sub-type: pCR-BLUNT
Availability: Please enquire for quantities and pricing
Target: Hepatitis B surface antigen
Bacterial Resistance: Kanamycin
Selectable Markers: Kanamycin
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Dr Oluwapelumi Adeyemi
Institute: University of Ilorin ; University of Leeds
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Tool name: pCRBLUNT-HBsAg Vector
- Research fields: Genetics;Microbiology
- Tool sub type: pCR-BLUNT
- Backbone size without insert: 3519
- Bacterial resistance: Kanamycin
- Selectable markers: Kanamycin
- Recommended controls: This construct is designed as positive control for diagnostic applications
Target Details
- Target: Hepatitis B surface antigen
References
- Adeyemi et al. 2017. J Med Virol. 89(11):1944-1951. PMID: 28618003.
![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)

![Anti-CAR Whitlow Linker [1B4A1]](https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-300x396.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-227x300.jpg 227w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-776x1024.jpg 776w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-768x1013.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 970w)


